DIANT Pharma
Storrs Mansfield · Founded 2019
About DIANT Pharma
DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines. They utilize a proprietary and continuous ethanol-injection system to form nanoparticles with controlled particle sizes at high flow rates, providing pharmaceutical companies with a continuous drug encapsulation technique to achieve their goals and high encapsulation processes. Founded in 2019, DIANT offers technology that is robust and reliable from R&D to manufacturing over a product’s lifespan.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.9M
- Last round: Equity Crowdfunding (May 2025)
- Website: https://diantpharma.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/diant-pharma-73187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.